It’s a busy week for initial public offerings with seven companies pricing shares this week.
Tuesday
Ambow Education Holding Ltd (NYSE:AMBO) will be the first IPO of the week. The company provides K-12 educational services to students in China, including online programs and tutoring services. The company will issue 1.5 million shares priced between US$3.50 and US$4.50, raising as much as US$6.75mln. On the OTCMarkets, the company’s shares jumped more than 90% to US$3.86.
Wednesday
Electronic payment processing company Evo Payments Inc (NASDQ:EVOP) will price its shares Wednesday. The Georgia-based company processes over US$100bn per year in transaction volume. The company will issue 14 million shares priced between US$14 and US$16, raising as much as US$210mln at the midpoint price.
Thursday
Biotech Scholar Rock Holding Corp (NASDAQ:SRRK) is pricing its shares on Thursday. The Massachusetts-based company develops medicines for diseases like neuromuscular disorders, cancer, fibrosis and anemia, but its most advanced treatment being developed is for spinal muscular atrophy. The company will issue around 5.4 million shares priced between US$13 and US$15, raising up to US$75.6mln at its midpoint price.
Financial IT services provider CPLS Inc (NASDAQ:CLPS) will also price its shares on Thursday. The firm provides financial institutions with a suite of software for banking, mobile and other services. The Shanghai-based company will issue 2 million shares priced between US$5 and US$5.50, raising as much as US$10.5mln at its midpoint price.
Kiniksa Pharmaceuticals Inc (NASDAQ:KNSA) shares will price too. The clinical-stage biopharma develops therapeutics with a focus on autoinflammatory and autoimmune conditions. The Massachusetts-based company will issue 7 million shares priced between US$17 and US$19, raising as much as US$126mln at its midpoint price.
Online lender GreenSky Inc (NASDAQ:GSKY) will be the fourth company to price its shares on Thursday. The fintech offers quick-decision loans to consumers looking to finance home improvements and other projects. The Atlanta-based company will issue more than 34 million shares priced between US$21 and US$23, raising as much as US$748mln at its midpoint price.
Friday
Iterum Therapeutics PLC (NASDAQ:ITRM) will price its shares at the end of the week. The clinical-stage pharmaceutical company develops anti-infectives to combat drug-resistant pathogens as well as treatments for urinary tract and intra-abdominal infections. The company is incorporated in Ireland but based in Chicago. Its antibiotic sulopenem, which is similar to penicillin, is moving into Phase 3 clinical trials after being licensed from Pfizer Inc (NYSE:PFE). The company will issue 5.3 million shares priced between US$14 and US$16, raising as much as US$79.5mln at its midpoint price.